Studies have found that all GLP-1 drugs can lead to weight loss of about 10.5 to 15.8 pounds (4.8 to 7.2 kilograms, or kg) when using liraglutide. Studies found people using semaglutide and making lifestyle changes lost about 33.7 pounds (15.3 kilograms) versus 5.7 pounds (2.6 kilograms) in those who didn’t use the drug.

Reference: GLP-1 agonists: Diabetes drugs and weight loss – Mayo Clinic

Evidence supports both GLP-1 agonists liraglutide and semaglutide as effective agents for weight loss in patients with obesity without diabetes, with semaglutide data providing a more significant weight loss in clinical trials.

Semaglutide is a prescription medication used to treat Type 2 Diabetes Mellitus and for Weight Management. Semaglutide is available under the following different brand names: Ozempic, Rybelsus, Wegovy.

Liraglutide injection is used to treat type 2 diabetes. It is used when diet and exercise alone do not result in good blood sugar control. It is also used to help reduce the risk of heart and blood vessel problems, including heart attacks and strokes in patients with type 2 diabetes and established heart or blood vessel disease.

Liraglutide is available under the following different brand names: Saxenda, Victoza.

Reference: Liraglutide (Subcutaneous Route) Description and Brand Names – Mayo Clinic

We recommend injecting your weekly dose into your abdomen, at least one inch away from your naval. Rotate injection sites each week. The injection supplies that we will provide are 31G 5/16” long insulin syringes that are measured in units. Each insulin syringe is safe to use for one injection. Do not use the same syringe for multiple injections. Dispose of your used syringe into a stiff/hard plastic resealable container, such as a detergent container.

The most common side effects include gastrointestinal related symptoms such as abdominal pain, constipation, diarrhea, nausea, and vomiting. These side effects may be more common after initiation (especially if using a higher dose than prescribed) and during dose escalation.

Extreme sensitivity reactions such as rash, trouble breathing, swelling of the mouth, face, or throat should be reported to your physician. Low blood sugar can occur and is marked by signs of dizziness, headache, feeling sleepy or weak, shaking, fast heartbeat, confusion, hunger, change in eyesight, or sweating. Discontinue use of the medication should these reactions occur.

At Lolachi Institute, you will get a Body Composition Analysis during your consultation visit with Dr. Lolachi.  Body fat percentage scales work by using bioelectrical impedance analysis (BIA). BIA is a method that uses tiny electrical impulses to estimate body composition. The device sends an electrical current from one foot, up one leg, across the stomach area and down the other leg into the second foot. The speed of the current is related to the amount of water in your body, and fat contains less water than muscle tissue.